Blog
RSS FeedPosted by Michael Wonder on 20 Aug 2020
Three-quarters of New Zealanders intend to get COVID-19 vaccine
20 August 2020 - Three-quarters of New Zealanders say they would get the Covid-19 vaccine once it becomes available, new ...
Posted by Michael Wonder on 17 Aug 2020
Irish pharmacists lobby for biosimilar substitution
17 August 2020 - Pharmacists in Ireland say the country is losing out on hundreds of millions of dollars in savings ...
Posted by Michael Wonder on 13 Aug 2020
Disney official, others, talk about switch to biosimilars
12 August 2020 - Dismayed at the low biosimilar uptake and the lost savings, large employers are taking matters into their ...
Posted by Michael Wonder on 13 Aug 2020
Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19
13 August 2020 - While the focus of attention currently is on developing a vaccine against the Coronavirus SARS-CoV-2 to protect ...
Posted by Michael Wonder on 03 Aug 2020
Slow start for infliximab biosimilars
3 August 2020 - Investigators speculate on why infliximab biosimilars don’t have a larger market share by now. ...
Posted by Michael Wonder on 27 Jul 2020
Biosimilar insulin glargine on the PBS - information for health professionals and patients
27 July 2020 - Changes have been made from 1 July 2020 to the PBS listings for insulin glargine, as the ...
Posted by Michael Wonder on 14 Jul 2020
Biosimilar Awareness Week proves successful for Australia
13 July 2020 - The Generic and Biosimilar Medicines Association in Australia reported its 2020 Biosimilar Awareness Week was successful, with ...
Posted by Michael Wonder on 07 Jul 2020
Remove the disincentives and biosimilars will flourish, policy expert says
7 July 2020 - Patients could save as much as 17% on out-of-pocket costs if they used biosimilars, but many ...
Posted by Michael Wonder on 07 Jul 2020
Use of infliximab biosimilar in Medicare population is low but growing
7 July 2020 - Slow growth of use of biosimilar infliximab in a Medicare fee-for-service population suggests lingering hesitancy on the ...
Posted by Michael Wonder on 29 Jun 2020
Demand for dexamethasone soars after promising findings in UK
27June 2020 - Weekly demand in the U.S. is up more than 600%. ...
Posted by Michael Wonder on 25 Jun 2020
The impact of drug quality ratings from health technology assessments on the adoption of new drugs by physicians in Germany
15 June 2020 - Payers are increasingly calling for the value of new drugs to be measured explicitly. ...
Posted by Michael Wonder on 24 Jun 2020
Looking back, UK patients unhappy with adalimumab biosimilar switch
24 June 2020 - The UK results show how challenging switching to a biosimilar can be, according to patient groups. ...
Posted by Michael Wonder on 15 Jun 2020
Rising costs explain why Canada is switching to biosimilars
15 June 2020 - Following in the footsteps of British Columbia, other Canadian provinces are working to implement their own biosimilars ...
Posted by Michael Wonder on 20 May 2020
Coverage for biosimilars vs reference products among US commercial health plans
19 May 2020 - The greater use of biosimilars may have the potential to help reduce drug costs. ...
Posted by Michael Wonder on 27 Apr 2020
Prescriptions surged as Trump praised drugs in coronavirus fight
25 April 2020 - Prescriptions for two antimalarial drugs jumped by 46 times the average when the president promoted them on ...